PCAF bromodomain (714-831 aa), human recombinant protein
PCAF bromodomain (714-831 aa) (GST-tagged), Human recombinant
|Calculated MW||40.9 kDa (714-831 aa + NT GST Tag)|
|Other Names||p300/CBP-associated factor; KAT2B|
|Storage||-80°C; 50 mM Tris, pH 8.0, containing 150 mM sodium chloride and 20% glycerol.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
The acetylation of histone lysine residues plays a crucial role in the epigenetic regulation of gene transcription. A bromodomain is a protein domain that recognizes acetylated lysine residues such as those on the N-terminal tails of histones. This recognition is often a prerequisite for protein-histone association and chromatin remodeling. These domains function in the linking of protein complexes to acetylated nucleosomes, thereby controlling chromatin structure and gene expression. Thus, bromodomains serve as “readers” of histone acetylation marks regulating the transcription of target promoters. p300/CBP-associated factor (PCAF) is a transcriptional coactivator that works both as a histone lysine acetyltransferase, through its HAT domain, and as an acetyl-lysine reader through its conserved bromodomain located directly C-terminal to the HAT domain. The PCAF bromodomain binds acetylated histone H3 and H4 as well as non-histone targets. Bromodomain binding is dictated by the position of the acetylated lysine as well as interactions with specific residues flanking the acetyl-lysine. PCAF also specifically binds the HIV viral protein Tat on acetylated K50 to regulate its transactivating activity and help induce chromatin remodeling of proviral genes, thereby promoting transcription of viral proteins.
Yang X.-J.,et al.Nature 382:319-324(1996).
Nakatani Y.,et al.Submitted (JUL-1999) to the EMBL/GenBank/DDBJ databases.
Ogryzko V.V.,et al.Cell 87:953-959(1996).
Takeshita A.,et al.J. Biol. Chem. 272:27629-27634(1997).
Spencer T.E.,et al.Nature 389:194-198(1997).
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at email@example.com.